insights_auto
Why is TWST up 2,10%?
Dive Deeperchevron_right
TWST:NASDAQ
Twist Bioscience Corp
142,70 USD
arrow_upward
+2,10%(+2,93) 1D
143,00 USD
arrow_upward
+0,21% (+0,30)bedtimeAfter hours
Closed: 20-окт., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TWST...
Open
139,77 USD
High
148,83 USD
Low
134,94 USD
Mkt. cap
9,46 млд
Avg. vol.
2,84 млн
Volume
968,00
52-wk high
219,71 USD
52-wk low
23,30 USD
EPS
-2,22 USD
Beta
2,19
Shares outstanding
65,83 млн
No. of employees
979
Open
139,77 USD
High
148,83 USD
Low
134,94 USD
Mkt. cap
9,46 млд
Avg. vol.
2,84 млн
Volume
968,00
52-wk high
219,71 USD
52-wk low
23,30 USD
EPS
-2,22 USD
Beta
2,19
Shares outstanding
65,83 млн
No. of employees
979
News stories
From web sources and news partners
ad-hoc-news.de
·
20 саат мурун
TD Cowen lifts target to USD 190 for Twist Bioscience stock
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp